Matches in Nanopublications for { ?s ?p "[In the PSS group the presence of at least either activating KIR2DS1 and/or 2DS2 was significantly increased in patients when compared with controls (P= 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP929448.RAS-yidl2cJB-AcKVvSbmRIykFU5RXSOM5ov2lGI9XKl0130_assertion description "[In the PSS group the presence of at least either activating KIR2DS1 and/or 2DS2 was significantly increased in patients when compared with controls (P= 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929448.RAS-yidl2cJB-AcKVvSbmRIykFU5RXSOM5ov2lGI9XKl0130_provenance.
- NP524491.RAK6SkELjKuubVdqpQjT5zl-5A26hXC8GwcnR-qLJZaGE130_assertion description "[In the PSS group the presence of at least either activating KIR2DS1 and/or 2DS2 was significantly increased in patients when compared with controls (P= 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524491.RAK6SkELjKuubVdqpQjT5zl-5A26hXC8GwcnR-qLJZaGE130_provenance.
- NP605446.RAL-TErkcKhVTcf6nByfyn2FvEKn7HGQnY4pj9FbA8oYA130_assertion description "[In the PSS group the presence of at least either activating KIR2DS1 and/or 2DS2 was significantly increased in patients when compared with controls (P= 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605446.RAL-TErkcKhVTcf6nByfyn2FvEKn7HGQnY4pj9FbA8oYA130_provenance.
- NP605459.RAICPlW4jt8sstpEp3YCwJV9xI8Lt_miuJjtzfuCcjbRE130_assertion description "[In the PSS group the presence of at least either activating KIR2DS1 and/or 2DS2 was significantly increased in patients when compared with controls (P= 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605459.RAICPlW4jt8sstpEp3YCwJV9xI8Lt_miuJjtzfuCcjbRE130_provenance.